Dr. Lin Mei is Professor and Chair, Department of Neurosciences, School of Medicine, Case Western Reserve University and Director, Cleveland Brain Health Initiative. He is the Allen C. Holmes Professor of Neurological Diseases, School of Medicine, Case Western Reserve University. Prior to the current positions, Dr. Mei was the Inaugural Chair, Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University; and was on faculty at Department of Pharmacology, University of Virginia and Department of Neurobiology, University of Alabama at Birmingham. Dr. Mei graduated from Jiangxi Medical College, Nanchang University and obtained MS in Neuropharmacology from Chinese Academy of Military Medical Sciences. After earning PhD in Pharmacology and Toxicology at University of Arizona, Dr. Mei went to Johns Hopkins School of Medicine for postdoctoral training.

Dr. Mei’s research focuses on neural development in particular neuromuscular junction formation, neurological disorders, and psychiatric disorders including schizophrenia and autism. He has identified novel antibodies in patients with myasthenia gravis and is now collaborating with 20 clinic centers in the nation to study these novel biomarkers. Dr. Mei’s research has been continuously supported by NIH for more than 20 years. He has authored more than 150 articles in peer-reviewed journals and more than 40 reviews or chapters. His findings have been cited in many textbooks including Molecular Biology of the Cell. Dr. Mei serves as editorial member, associate editor or section editor for 9 journals including Journal of Neuroscience. Dr. Mei have received numerous awards Distinguishes Investigator from National Alliance for Research on Schizophrenia and Depression (2008) and Mathilde Solowey Award from Foundation for Advanced Education in Sciences (2008). Dr. Mei was elected as Fellow of American Association for the Advancement of Science in 2013.